ONZETRA XSAIL

Drug Currax Pharmaceuticals LLC
Total Payments
$449,215
Transactions
7,437
Doctors
3,199
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $35,923 2,336 1,279
2023 $87,266 3,690 1,947
2022 $245,344 354 196
2021 $26,256 420 209
2020 $54,220 618 256
2019 $206.64 19 16

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $281,437 47 62.7%
Food and Beverage $101,719 7,356 22.6%
Honoraria $43,950 21 9.8%
Consulting Fee $20,645 8 4.6%
Travel and Lodging $1,464 5 0.3%

Payments by Type

Research
$281,437
47 transactions
General
$167,778
7,390 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
17-AVP-825-301_Clinical Operations Currax Pharmaceuticals LLC $281,437 0

Top Doctors Receiving Payments for ONZETRA XSAIL

Doctor Specialty Location Total Records
Unknown Anaheim, CA $281,466 49
, MD Neurology Amherst, NY $8,050 2
, MD Adult Medicine Irvine, CA $6,125 3
, M.D Neurology Lebanon, NH $5,500 1
, M.D Neurology Carlsbad, CA $5,500 2
, MD Neurology Amherst, NY $5,317 47
, M.D Neurology Los Angeles, CA $4,000 1
, DRNP Adult Health Scottsdale, AZ $3,798 6
, M.D Neurology Fairfield, CT $2,250 1
, M.D Neuromuscular Medicine Abington, PA $2,250 1
, MD Specialist Englewood, CO $2,031 11
, M.D Neuro-ophthalmology Carlsbad, CA $2,000 1
, MD Neurology Stanford, CA $2,000 1
, M.D Neurology San Francisco, CA $2,000 1
, DMD Dentist Ojai, CA $1,856 3
, D.O Neurology Phoenix, AZ $1,750 1
, D.O Neurology Irvine, CA $1,750 1
, D.M.D Orofacial Pain Loma Linda, CA $1,750 1
, M.D Pain Medicine Los Angeles, CA $1,750 1
, M.D Neurology Fulton, MD $1,679 49
, M.D Neurology Plainview, NY $1,500 1
, DO Internal Medicine Dallas, TX $1,440 13
Damita Bryant Nashville, TN $1,191 7
, M.D Neurology Carlsbad, CA $1,050 2
, M.D Specialist Brooklyn, NY $796.03 7

About ONZETRA XSAIL

ONZETRA XSAIL is a drug associated with $449,215 in payments to 3,199 healthcare providers, recorded across 7,437 transactions in the CMS Open Payments database. The primary manufacturer is Currax Pharmaceuticals LLC.

Payment data is available from 2019 to 2024. In 2024, $35,923 was paid across 2,336 transactions to 1,279 doctors.

The most common payment nature for ONZETRA XSAIL is "Unspecified" ($281,437, 62.7% of total).

ONZETRA XSAIL is associated with 1 research study, including "17-AVP-825-301_Clinical Operations" ($281,437).